Skip to main content
. 2021 Mar 3;99(5):300–309. doi: 10.1159/000512967

Fig. 3.

Fig. 3

Median progression-free survival (mPFS; a) and median overall survival (mOS; b) curves with unresectable cholangiocarcinoma. PFS was defined as the time from start of chemotherapy until disease progression or death from any cause. OS was defined as the time from start of chemotherapy until death from any cause. Vertical lines indicate that patients' data were censored.